TP53 and liver cancer: Curated data from public databases (IARC TP53, COSMICs, ICGC, and cBioportal) reveal the presence of Arg158 mutp53 in multiple carcinomas; and the effectiveness of mutp53 acetylators in the PDX models of gastric and liver cancers further extends the applicability of these findings to other cancer types.